NIH Issues Draft of Guidelines Governing Stem Cell Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

BETHESDA, Md—The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

The guidelines sanction research on cell lines from fetal tissue, work that develops new cells lines from fetal tissue, and research on cell lines privately derived from human embryos.

The guidelines prohibit studies that would create or contribute to a human embryo, combine human stem cells with an animal embryo, or engage in reproductive cloning of a human. Also barred are studies in which stem cells are derived using somatic cell nuclear transfer into a human or animal egg, and those in which stem cells are derived from human embryos created for

Recent Videos
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.